2334
As an oral , nontoxic compound with a mechanism of action distinct from that of ABL tyrosine kinase inhibition , FTI SCH66336 shows promise for the treatment of BCR / ABL - induced leukemia .
 GENE: ABL tyrosine kinase; GENE: BCR; GENE: ABL
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: GENE 
Text: {0} 
Answer:
 GENE: ABL tyrosine kinase; GENE: BCR; GENE: ABL